Most recently, Chen et al.performed comprehensive proteomic and drug-screening studies across pan-cancer models and confirmed that FAT1 mutated HNSCC had selective and higher sensitivity to BRD4 inhibition by JQ1 which has been also used to block YAP1 signaling [55]. The gene discussed is YAP1; the disease is head and neck squamous cell carcinoma.